AstraZeneca, Russia's Sputnik V developer to sign cooperation memorandum

Britain’s AstraZeneca and Russia's Gamaleya Institute, which developed the Sputnik V vaccine, will sign a memorandum of intent on cooperation on Monday, the Kremlin said.
 
Russia’s RDIF sovereign wealth fund said this month AstraZeneca would start clinical trials to test a combination of its experimental Covid-19 vaccine with the Sputnik V shot to see if this can boost the efficacy of the British drugmaker's vaccine.
 
President Vladimir Putin hailed British drugmaker AstraZeneca's decision to test combining its own experimental Covid-19 vaccine with Russia's Sputnik V shot.
 
Clinical trials, still under way, have shown Sputnik has an efficacy